XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44 | -17.0% | 20,700 | +2.0% | 0.00% | – |
| Q2 2023 | $53 | -11.7% | 20,300 | +8.0% | 0.00% | – |
| Q1 2023 | $60 | -40.0% | 18,800 | -49.3% | 0.00% | – |
| Q4 2022 | $100 | -99.9% | 37,100 | +30.2% | 0.00% | – |
| Q3 2022 | $83,000 | -62.3% | 28,500 | -62.2% | 0.00% | – |
| Q2 2022 | $220,000 | – | 75,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,441,444 | $3,041,447 | 7.52% |
| Trustees of Columbia University in the City of New York | 249,635 | $526,730 | 0.97% |
| Atlas Venture Life Science Advisors, LLC | 2,759,344 | $5,822,216 | 0.90% |
| Octagon Capital Advisors LP | 2,318,500 | $4,892,035 | 0.75% |
| Bain Capital Life Sciences Investors, LLC | 2,805,413 | $5,919,421 | 0.66% |
| HARVARD MANAGEMENT CO INC | 416,059 | $878 | 0.10% |
| Rock Springs Capital Management LP | 1,440,759 | $3,040,001 | 0.08% |
| Soleus Capital Management, L.P. | 226,941 | $478,846 | 0.04% |
| Artal Group S.A. | 450,000 | $950 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 110,481 | $233,115 | 0.01% |